Conducting Clinical Trials With Decentralized Elements
The FDA has issued final Level 1 guidance (Docket Number: FDA-2022-D-2870) from the Center for Drug Evaluation and Research, the Center for …
Read more
Argentina ANMAT proposes guidelines for decentralized c…
Argentina ANMAT guide outlines the requirements for decentralized elements in clinical pharmacology studies, including roles and responsibil…
Read more